Therefore, to determine how BAFF directly affects T cells without affecting B cells or without interference effect on other immune cells (such as APC, interleukins, and so on), we examined whether belimumab could modulate acute GVHD by transplanting only splenic CD4+ T cells using GVHD protocol 2. Here, CD4 is linked to acute graft versus host disease.